Federated Hermes’s CureVac CVAC Stock Holding History

Federated Hermes’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-40,000	Closed	-$273K	–	2071
2023 Q3	$273K	Buy	40,000 +10,000	+33%	+$88.3K	﹤0.01%	1478
2023 Q2	$313K	Sell	30,000 -10,000	-25%	-$89.4K	﹤0.01%	1488
2023 Q1	$279K	Buy	+40,000	New	+$349K	﹤0.01%	1536
2022 Q2	–	Sell	-169	Closed	-$3K	–	2177
2022 Q1	$3K	Buy	+169	New	+$3.37K	﹤0.01%	1993

Other funds holding CVAC

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Federated Hermes's CVAC Position: Q4 2023 in Review

Federated Hermes sold out of CureVac (CVAC) in Q4 2023, closing a stake of 40,000 shares — an estimated $273K sold.

Federated Hermes first reported a position in CVAC in Q1 2022 and held it in 4 quarters. The position peaked at $313K in Q2 2023. 90 funds tracked by Wall St. Rank hold CVAC as of Q4 2023.

Federated Hermes reported no remaining CureVac position as of Q4 2023 after selling out during the quarter.
Federated Hermes sold 40,000 CureVac shares in Q4 2023, an estimated $273K.
Federated Hermes first reported a position in CureVac in Q1 2022 and held it in 4 quarters.
Federated Hermes's CureVac position peaked at $313K in Q2 2023.
90 funds tracked by Wall St. Rank held CureVac as of Q4 2023.

Based on Federated Hermes's 13F filing for Q4 2023, filed 31 Jan 2024.